JP2017530193A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017530193A5 JP2017530193A5 JP2017535616A JP2017535616A JP2017530193A5 JP 2017530193 A5 JP2017530193 A5 JP 2017530193A5 JP 2017535616 A JP2017535616 A JP 2017535616A JP 2017535616 A JP2017535616 A JP 2017535616A JP 2017530193 A5 JP2017530193 A5 JP 2017530193A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- heteroaryl
- heterocycloalkyl
- aryl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RXYPXQSKLGGKOL-UHFFFAOYSA-N CN1CCN(C)CC1 Chemical compound CN1CCN(C)CC1 RXYPXQSKLGGKOL-UHFFFAOYSA-N 0.000 description 2
- TZYFCEGYHDNOFE-UHFFFAOYSA-N CC(CC1N(C)CCCC1)[n]1nncc1 Chemical compound CC(CC1N(C)CCCC1)[n]1nncc1 TZYFCEGYHDNOFE-UHFFFAOYSA-N 0.000 description 1
- PAMIQIKDUOTOBW-UHFFFAOYSA-N CN1CCCCC1 Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 1
- JWAWEQBUZOGIBZ-UHFFFAOYSA-N C[n]1nncc1 Chemical compound C[n]1nncc1 JWAWEQBUZOGIBZ-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462053389P | 2014-09-22 | 2014-09-22 | |
| US62/053,389 | 2014-09-22 | ||
| PCT/US2015/051143 WO2016048861A2 (en) | 2014-09-22 | 2015-09-21 | Heterocyclic compounds and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017530193A JP2017530193A (ja) | 2017-10-12 |
| JP2017530193A5 true JP2017530193A5 (enExample) | 2018-11-01 |
| JP6615207B2 JP6615207B2 (ja) | 2019-12-04 |
Family
ID=55525127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017535616A Active JP6615207B2 (ja) | 2014-09-22 | 2015-09-21 | 複素環式化合物及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9862703B2 (enExample) |
| EP (1) | EP3197885B1 (enExample) |
| JP (1) | JP6615207B2 (enExample) |
| KR (1) | KR102509431B1 (enExample) |
| CN (1) | CN107207465B (enExample) |
| AU (1) | AU2015321654B2 (enExample) |
| BR (1) | BR112017005713B1 (enExample) |
| CA (1) | CA2962329C (enExample) |
| ES (1) | ES2849998T3 (enExample) |
| RU (1) | RU2704008C2 (enExample) |
| TW (1) | TWI598348B (enExample) |
| WO (1) | WO2016048861A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6982716B2 (ja) * | 2017-01-10 | 2021-12-17 | ナショナル ヘルス リサーチ インスティチューツ | 複素環式化合物及びその使用 |
| MX2020002646A (es) * | 2017-09-08 | 2020-09-25 | Univ Leland Stanford Junior | Inhibidores de enpp1 y su uso para el tratamiento del cancer. |
| EP3842435A4 (en) | 2018-09-20 | 2022-05-11 | Hanmi Pharm. Co., Ltd. | NOVEL SULFONAMIDE DERIVATIVE WITH FUSED PYRIMIDINE FRAMEWORK WITH INHIBITING ACTIVITY ON EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS |
| MA54879A (fr) * | 2019-02-01 | 2021-12-08 | Univ Leland Stanford Junior | Inhibiteurs d'enpp1 et méthodes de modulation de réponse immunitaire |
| CN111138417B (zh) * | 2019-12-18 | 2021-03-23 | 浙江工业大学 | 一种三氮唑修饰的5-氟-2,4-嘧啶二胺类化合物及其应用 |
| CA3228210A1 (en) * | 2021-08-02 | 2023-02-09 | National Health Research Institutes | Pyrimidine compounds and use thereof |
| EP4617268A1 (en) * | 2022-11-07 | 2025-09-17 | Kyoto University | Quinazoline derivatives |
| TW202435887A (zh) | 2023-03-01 | 2024-09-16 | 瑞士商諾華公司 | 用於治療疾病或障礙的氫喹唑啉衍生物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4936700A (enExample) * | 1972-08-16 | 1974-04-05 | ||
| JPH08502721A (ja) * | 1992-04-03 | 1996-03-26 | ジ・アップジョン・カンパニー | 医薬的に活性な二環式‐複素環アミン |
| US6156758A (en) * | 1999-09-08 | 2000-12-05 | Isis Pharmaceuticals, Inc. | Antibacterial quinazoline compounds |
| CA2656290A1 (en) * | 2006-07-05 | 2008-01-10 | Exelixis, Inc. | Methods of using igf1r and abl kinase modulators |
| JP5690715B2 (ja) * | 2008-03-28 | 2015-03-25 | アルテイリス・セラピユーテイクス | ケモカイン受容体調節因子 |
| CN102046609B (zh) * | 2008-03-31 | 2014-05-14 | 全药工业株式会社 | 具有细胞保护效果的嘧啶衍生物及其应用 |
| DK2268635T3 (en) | 2008-04-21 | 2015-09-14 | Taigen Biotechnology Co Ltd | Heterocyclic Compounds |
| WO2010046780A2 (en) | 2008-10-22 | 2010-04-29 | Institut Pasteur Korea | Anti viral compounds |
| GB201015411D0 (en) | 2010-09-15 | 2010-10-27 | Univ Leuven Kath | Anti-cancer activity of novel bicyclic heterocycles |
| EP2771337B1 (en) | 2011-09-27 | 2017-08-02 | Novartis AG | 3-(pyrimidin-4-yl)-oxazolidin-2-ones as inhibitors of mutant idh |
| CN104379180A (zh) | 2012-04-10 | 2015-02-25 | 佐治亚州立大学研究基金会公司 | 用cyld抑制剂治疗中耳炎及其它病状的组合物和方法 |
| NZ705589A (en) | 2012-10-10 | 2019-05-31 | Janssen Sciences Ireland Uc | Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases |
| WO2014074517A1 (en) * | 2012-11-08 | 2014-05-15 | Emory University | Cellular compositions used to restore stem cell or progenitor cell function and methods related thereto |
-
2015
- 2015-09-21 AU AU2015321654A patent/AU2015321654B2/en active Active
- 2015-09-21 RU RU2017109355A patent/RU2704008C2/ru active
- 2015-09-21 CN CN201580050829.5A patent/CN107207465B/zh active Active
- 2015-09-21 KR KR1020177010762A patent/KR102509431B1/ko active Active
- 2015-09-21 EP EP15844487.7A patent/EP3197885B1/en active Active
- 2015-09-21 JP JP2017535616A patent/JP6615207B2/ja active Active
- 2015-09-21 WO PCT/US2015/051143 patent/WO2016048861A2/en not_active Ceased
- 2015-09-21 CA CA2962329A patent/CA2962329C/en active Active
- 2015-09-21 ES ES15844487T patent/ES2849998T3/es active Active
- 2015-09-21 US US14/860,033 patent/US9862703B2/en active Active
- 2015-09-21 BR BR112017005713-1A patent/BR112017005713B1/pt active IP Right Grant
- 2015-09-22 TW TW104131241A patent/TWI598348B/zh active
-
2017
- 2017-09-22 US US15/712,978 patent/US9926298B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017530193A5 (enExample) | ||
| RU2017109355A (ru) | Гетероциклические соединения и их применение | |
| PE20141700A1 (es) | Compuestos de 2-(2,4,5-anilino sustituido) pirimidina | |
| CY1118909T1 (el) | Αμιδια οξαλικου οξεος ως αναστολεις νεπριλυσινης, φαρμακευτικη συνθεση αυτων και παρασκευη αυτων | |
| JP2016518328A5 (enExample) | ||
| JP2015522650A5 (enExample) | ||
| JP2016516043A5 (enExample) | ||
| JP2016053042A5 (enExample) | ||
| JP2016540803A5 (enExample) | ||
| AR086983A1 (es) | Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de jak | |
| PE20190395A1 (es) | Pirimidin-2-ilamino-1h-pirazoles como inhibidores de lrrk2 para el uso en el tratamiento de trastornos neurodegenerativos | |
| JP2016515560A5 (enExample) | ||
| JP2014506599A5 (enExample) | ||
| JP2017509586A5 (enExample) | ||
| JP2007524696A5 (enExample) | ||
| RU2013109132A (ru) | Химические соединения | |
| JP2015534574A5 (enExample) | ||
| AR081587A1 (es) | DERIVADOS DE 5,6-DIHIDRO-2H-[1,4]OXAZIN-3-IL-AMINA UTILES COMO INHIBIDORES DE LA b-SECRETASA (BACE) | |
| JP2020500869A5 (enExample) | ||
| JP2019529419A5 (enExample) | ||
| AR073551A1 (es) | Pirimidinas macrociclicas como inhibidores de proteina cinasa | |
| RU2020131276A (ru) | Терапевтические соединения и композиции | |
| JP2016513696A5 (enExample) | ||
| PE20080856A1 (es) | Inhibidores de metaloproteasas de matriz | |
| JP2015535851A5 (enExample) |